| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/24/2005 | US20050063975 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063970 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 03/24/2005 | US20050063969 Assay |
| 03/24/2005 | US20050063968 A monoclonal antibody specific for MOAT proteins; expression vectors, host cells, transgenic mice, and screening; inhibition of MOAT mediated transport is indicated by restoration of anticancer drug sensitivity |
| 03/24/2005 | US20050063957 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 03/24/2005 | US20050063952 Immunogenic CEA |
| 03/24/2005 | US20050063951 Function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 03/24/2005 | US20050063948 Methods for targeting interleukin-12 to malignant endothelium |
| 03/24/2005 | US20050063946 Human pluripotent hematopoietic colony stimulating factor, method of production and use |
| 03/24/2005 | US20050063945 Fusion protein of two different cytokines, one capable of enhancing a nonspecific immune response, and the other capable of enhancing a specific immunity; fusion protein of Interleukin-2 (Il-2) and IL-7 for example; use in immunotherapy such as cancer vaccine |
| 03/24/2005 | US20050063937 Multiple-arm peptide compounds, methods of manufacture and use in therapy |
| 03/24/2005 | DE10339927A1 Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen A composition for prophylaxis / therapy of HBV infection and HBV-mediated diseases |
| 03/24/2005 | DE10339567A1 Isoliertes Photoprotein Berovin, sowie dessen Verwendung The isolated photoprotein berovin, and its use |
| 03/24/2005 | DE10338733A1 Fusionspolypeptide und deren Verwendung für die antivaskuläre Tumortherapie Fusion polypeptides and their use for the anti-vascular cancer therapy |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2539380A1 Method for producing insulin from a natural source and insulin |
| 03/24/2005 | CA2538843A1 Animal model for protease activity and liver damage |
| 03/24/2005 | CA2538763A1 Monoclonal antibodies against hmgb1 |
| 03/24/2005 | CA2538528A1 Genetic products which are differentially expressed in tumours and use thereof |
| 03/24/2005 | CA2538514A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 03/24/2005 | CA2538495A1 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538461A1 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538442A1 Eukaryotic genes for modulating cell cycle progression |
| 03/24/2005 | CA2538069A1 Effectors of innate immunity determination |
| 03/24/2005 | CA2537931A1 Multi-antigen vectors for melanoma |
| 03/24/2005 | CA2537489A1 Vaccines |
| 03/24/2005 | CA2537429A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | CA2536989A1 Lawsonia intracellularis subunit vaccine |
| 03/24/2005 | CA2536735A1 Methods for determining cd8+ t-cell epitopes |
| 03/24/2005 | CA2536655A1 Immortalisation of mammalian cells and therapeutic applications of said cells |
| 03/24/2005 | CA2536652A1 Piroplasmid vaccine |
| 03/24/2005 | CA2536396A1 Methods of using wisp antagonists |
| 03/24/2005 | CA2535221A1 Chimeric gabab receptor |
| 03/24/2005 | CA2534442A1 Adipocyte complement related protein zacrp12 |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516930A1 Cellular model of tauopathies for lead identification and drug discovery |
| 03/23/2005 | EP1516274A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/23/2005 | EP1516190A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 03/23/2005 | EP1516189A2 Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases |
| 03/23/2005 | EP1516188A2 Method for identifying and extracting endotoxin |
| 03/23/2005 | EP1516184A2 Cell penetrating peptides |
| 03/23/2005 | EP1516061A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 03/23/2005 | EP1516058A2 Recombinant measles viruses expressing epitopes of antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 03/23/2005 | EP1516055A2 Fiber shaft modifications for efficient targeting |
| 03/23/2005 | EP1516054A2 Fusion constructs containing active sections of tnf ligands |
| 03/23/2005 | EP1516050A2 Generation of plants with improved pathogen resistance |
| 03/23/2005 | EP1516049A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2005 | EP1515991A2 Pain signaling molecules |
| 03/23/2005 | EP1515990A2 Antagonists of cxcr3-binding cxc chemokines |
| 03/23/2005 | EP1515989A1 Immunogenic conjugates |
| 03/23/2005 | EP1515988A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 03/23/2005 | EP1515987A2 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | EP1515981A4 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 03/23/2005 | EP1515981A2 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 03/23/2005 | EP1515746A2 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity |
| 03/23/2005 | EP1515745A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 03/23/2005 | EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515738A2 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 03/23/2005 | EP1515614A1 Protein extraction from canola oil seed meal |
| 03/23/2005 | EP1515601A2 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 03/23/2005 | EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 03/23/2005 | EP1328540B1 Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150 |
| 03/23/2005 | EP1311285B1 Liquid pharmaceutical composition containing an erythropoietin derivative |
| 03/23/2005 | EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules |
| 03/23/2005 | EP1198478B1 Somatostatin analogs and their use for the treatment of cancer |
| 03/23/2005 | EP1185623A4 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors |
| 03/23/2005 | EP1114166B1 Method for down-regulating osteoprotegerin ligand activity |
| 03/23/2005 | EP1068232B1 Human antibiotic protein |
| 03/23/2005 | EP1012311B1 G protein chimeras |
| 03/23/2005 | EP0981636B1 Lentivirus-based gene transfer vectors |
| 03/23/2005 | EP0968297B1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector |
| 03/23/2005 | EP0939813B1 Breast carcinoma-associated gene |
| 03/23/2005 | EP0937104B1 Endothelium specific expression regulated by epcr control elements |
| 03/23/2005 | EP0879283B1 Glutenin genes and their uses |
| 03/23/2005 | EP0845005B1 Traf inhibitors |
| 03/23/2005 | EP0832241B1 Mutants of streptococcal toxin a and methods of use |
| 03/23/2005 | EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein |
| 03/23/2005 | EP0723398B1 Superoxide dismutase mimetics |
| 03/23/2005 | EP0674712B1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 03/23/2005 | EP0672146B1 Biocidal chitin binding proteins |
| 03/23/2005 | EP0662092B1 Activity-dependent neurotrophic factor |
| 03/23/2005 | EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 03/23/2005 | CN1599867A Immunocytokines with modulated selectivity |
| 03/23/2005 | CN1599794A Production of viruses, viral isolates and vaccines |
| 03/23/2005 | CN1599753A Gene regulatory peptides |
| 03/23/2005 | CN1599752A Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599748A Novel peptides and medicinal uses thereof |
| 03/23/2005 | CN1599747A Isolation of lectins |
| 03/23/2005 | CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 03/23/2005 | CN1599622A Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease |
| 03/23/2005 | CN1599619A Methods and compositions for treating dermal lesions |
| 03/23/2005 | CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/23/2005 | CN1599616A Storage-stable human fibrinogen solutions |